Teva Paid 0.3% Local Tax Rate in 2012

Biggest reason for paying record low taxes is that the company does not pay Israel on profits from its flagship branded drug Copaxone for treating multiple sclerosis.

Yoram Gabison
Yoram Gabison
Send in e-mailSend in e-mail
Yoram Gabison
Yoram Gabison

Comments